MedTrace Logo

Cardiovascular Patients With no Standard Modifiable Risk Factors

NCT06199869 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5540

Last updated 2025-02-25

No results posted yet for this study

Summary

A growing number of patients develop atherosclerotic cardiovascular disease (ASCVD) despite the absence of standard modifiable risk factors (SMuRF-less). There is scarcity of studies that address this issue in the Middle Eastern population.

Conditions

  • Cardiovascular Risk Factors

Interventions

OTHER

Evaluation of risk factors by direct interview with subjects who have atherosclerotic cardiovascular patients

Individuals identified with a diagnosis of ASCVD will fill a one page form of the associated risk factors they have

Sponsors & Collaborators

  • The Jordan Cardiovascular Research Group JoCVRG

    collaborator OTHER

  • Yarmouk University School of Medicine

    collaborator UNKNOWN

  • Jordan Collaborating Cardiology Group

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-22
Primary Completion
2025-01-01
Completion
2025-01-31

Countries

  • Jordan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06199869 on ClinicalTrials.gov